Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic
- PMID: 8557072
- PMCID: PMC2271609
- DOI: 10.1017/s0950268800058568
Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic
Abstract
Vaccination against Neisseria meningitidis is not part of routine immunization schemes in any country; instead, targeted vaccination of groups at the highest risk is recommended during outbreaks and epidemics. After a long period of sporadic occurrence of meningococcal invasive disease, a new clone of Neisseria meningitidis C:2a:P1.2, ET-15/37, occurred in the Czech Republic, and caused local outbreaks in two neighbouring districts, Olomouc and Bruntal, in spring 1993. In Olomouc, a mass campaign was conducted during which 6191 students were vaccinated (5.6% of the total population of this locality and 96% of all students in the age group 15-19) within 2 weeks in June 1993. In Bruntal district, no such campaign was organized. In Olomouc, the incidence of invasive disease caused by Neisseria meningitidis C in the age group 10-24 decreased from 57 to 0 per 100,000 (P < 0.001) during the post-vaccination period (July 1993-August 1994), but no such decrease was observed in Bruntal. Although other factors can affect the frequency of disease, these results support the current recommendations of targeted vaccination in outbreaks of meningococcal disease.
Similar articles
-
Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.Cent Eur J Public Health. 1995 Nov;3(4):189-94. Cent Eur J Public Health. 1995. PMID: 8903519
-
[Evaluation of the effectiveness of targeted vaccination with the meningococcal polysaccharide A and C vaccine in one location in the Czech Republic].Epidemiol Mikrobiol Imunol. 1995 Mar;44(1):9-14. Epidemiol Mikrobiol Imunol. 1995. PMID: 7757351 Czech.
-
Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.Cent Eur J Public Health. 1997 Dec;5(4):214-8. Cent Eur J Public Health. 1997. PMID: 9457424
-
[Meningococcal disease in the Netherlands: media hype, but not an epidemic].Ned Tijdschr Geneeskd. 2001 Sep 8;145(36):1716-8. Ned Tijdschr Geneeskd. 2001. PMID: 11572168 Review. Dutch.
-
The Changing Epidemiology of Meningococcal Disease.Infect Dis Clin North Am. 2015 Dec;29(4):667-77. doi: 10.1016/j.idc.2015.08.002. Infect Dis Clin North Am. 2015. PMID: 26610420 Review.
Cited by
-
Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread.Clin Diagn Lab Immunol. 2000 May;7(3):390-5. doi: 10.1128/CDLI.7.3.390-395.2000. Clin Diagn Lab Immunol. 2000. PMID: 10799451 Free PMC article.
-
Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells.PLoS Pathog. 2014 Jun 12;10(6):e1004160. doi: 10.1371/journal.ppat.1004160. eCollection 2014 Jun. PLoS Pathog. 2014. PMID: 24945304 Free PMC article.
-
Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C.Eur J Clin Microbiol Infect Dis. 1998 Feb;17(2):85-9. doi: 10.1007/BF01682161. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9629971
-
Meningococcal vaccines. Current status and future possibilities.Drugs. 1998 Mar;55(3):347-66. doi: 10.2165/00003495-199855030-00003. Drugs. 1998. PMID: 9530542 Review.
-
Pathogenic neisseriae: surface modulation, pathogenesis and infection control.Nat Rev Microbiol. 2009 Apr;7(4):274-86. doi: 10.1038/nrmicro2097. Nat Rev Microbiol. 2009. PMID: 19287450 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical